The authors completed a review of 18 individual papers that consisted of 16 unique studies on GLP1-RAs and their effectiveness in reducing UACR in T2 DM as a possible tool to treat patients with DKD or at high risk of DKD. The gene discussed is GLP1R; the disease is diabetic kidney disease.